The drug is currently being assessed in a phase 1b/2a clinical trial
The drug is the first to be approved in Japan to treat children and adolescents with generalised myasthenia gravis
Updated Date: Wed, 16 Aug 2023 00:00:00 EDT
Updated Date: Wed, 16 Aug 2023 00:00:00 EDT
Updated Date: Wed, 16 Aug 2023 00:00:00 EDT
ONESKIN OS-01 SHIELD BROAD SPECTRUM SPF 30 MINERAL SUNSCREEN TINTED (zinc oxide) cream [Allure Labs]
Updated Date: Wed, 16 Aug 2023 00:00:00 EDT
Updated Date: Wed, 16 Aug 2023 00:00:00 EDT
Launer describes the devastating effects of nuclear weapons and highlights the moral responsibility of medical professionals to prioritise […]
Myrian describes the challenges she faces engaging in healthcare consultations after an acquired brain injury.1Her brain injury is […]
The decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy